0001209191-18-057421.txt : 20181106
0001209191-18-057421.hdr.sgml : 20181106
20181106164537
ACCESSION NUMBER: 0001209191-18-057421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181102
FILED AS OF DATE: 20181106
DATE AS OF CHANGE: 20181106
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sachdev Amit
CENTRAL INDEX KEY: 0001406338
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 181163593
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-11-02
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001406338
Sachdev Amit
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, CRO
Common Stock
2018-11-02
4
M
0
2155
91.05
A
48817
D
Common Stock
2018-11-02
4
S
0
600
171.93
D
48217
D
Common Stock
2018-11-02
4
S
0
1255
172.81
D
46962
D
Common Stock
2018-11-02
4
S
0
100
173.35
D
46862
D
Common Stock
2018-11-02
4
S
0
100
175.31
D
46762
D
Common Stock
2018-11-02
4
S
0
100
176.04
D
46662
D
Common Stock
2018-11-05
4
M
0
1941
86.52
A
48603
D
Common Stock
2018-11-05
4
S
0
300
172.70
D
48303
D
Common Stock
2018-11-05
4
S
0
1213
173.74
D
47090
D
Common Stock
2018-11-05
4
S
0
428
174.41
D
46662
D
Common Stock
12215
I
Held in Trust
Common Stock
882
I
401(k)
Stock Option (Right to Buy)
91.05
2018-11-02
4
M
0
2155
0.00
A
2026-02-01
Common Stock
2155
10777
D
Stock Option (Right to Buy)
86.52
2018-11-05
4
M
0
1941
0.00
A
2027-02-02
Common Stock
1941
17475
D
Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $171.93 (range $171.25 to $172.24).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $172.81 (range $172.32 to $173.27).
Open market sales reported on this line occurred at a weighted average price of $172.70 (range $172.16 to $173.12).
Open market sales reported on this line occurred at a weighted average price of $173.74 (range $173.28 to $174.15).
Open market sales reported on this line occurred at a weighted average price of $174.41(range $174.31 to $174.50).
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 02/03/2017.
/s/ Omar White, Attorney-in-Fact
2018-11-06